Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-12-09
DOI
10.1093/jnci/djaa201
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
- (2020) Kimberly H. Allison et al. JOURNAL OF CLINICAL ONCOLOGY
- Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration
- (2019) Samuel C.Y. Leung et al. HISTOPATHOLOGY
- Efficacy of de‐escalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple‐negative early breast cancer: Primary translational analysis of the WSG‐ADAPT‐TN trial
- (2019) Oleg Gluz et al. INTERNATIONAL JOURNAL OF CANCER
- A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients
- (2019) Angel Arnaout et al. BREAST CANCER RESEARCH AND TREATMENT
- Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients
- (2019) Angel Arnaout et al. BREAST CANCER RESEARCH AND TREATMENT
- Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update
- (2019) Kala Visvanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Primary Antibody Clone, Format, and Stainer Platform on Ki67 Proliferation Indices in Breast Carcinomas
- (2019) Rasmus Røge et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2− Breast Cancer
- (2019) Sara A. Hurvitz et al. CLINICAL CANCER RESEARCH
- Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)
- (2019) John F.R. Robertson et al. CLINICAL CANCER RESEARCH
- NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2+
- (2019) Louis Fehrenbacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer
- (2018) Armando E. Giuliano et al. ANNALS OF SURGICAL ONCOLOGY
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
- (2018) Willi Sauerbrei et al. JNCI-Journal of the National Cancer Institute
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
- (2018) Willi Sauerbrei et al. JNCI-Journal of the National Cancer Institute
- Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment
- (2018) Essam Ayad et al. Diagnostic Pathology
- Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study
- (2018) Balazs Acs et al. LABORATORY INVESTIGATION
- An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer
- (2018) David L. Rimm et al. MODERN PATHOLOGY
- Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial
- (2018) Stephen Johnston et al. JOURNAL OF CLINICAL ONCOLOGY
- Interlaboratory variability of Ki67 staining in breast cancer
- (2017) Cornelia M. Focke et al. EUROPEAN JOURNAL OF CANCER
- Comparison of 5 Ki-67 antibodies regarding reproducibility and capacity to predict prognosis in breast cancer: does the antibody matter?
- (2017) Balázs Ács et al. HUMAN PATHOLOGY
- Technical note: EnVision™ FLEX improves the detectability of depletions of myoglobin and troponin T in forensic cases of myocardial ischemia/infarction
- (2017) Sara Sabatasso et al. INTERNATIONAL JOURNAL OF LEGAL MEDICINE
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
- (2017) Ian Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
- (2017) W. Fraser Symmans et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
- (2017) Matthew J. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical relevance and concordance of HER2 status in local and central testing—an analysis of 1581 HER2-positive breast carcinomas over 12 years
- (2017) Berit M Pfitzner et al. MODERN PATHOLOGY
- Quality assurance trials for Ki67 assessment in pathology
- (2017) M. Raap et al. VIRCHOWS ARCHIV
- Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial
- (2016) John M. S. Bartlett et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial
- (2016) Torsten O. Nielsen et al. CLINICAL CANCER RESEARCH
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Lyndsay N. Harris et al. JOURNAL OF CLINICAL ONCOLOGY
- Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines – a Swedish survey with central re-assessment
- (2015) Maria Ekholm et al. ACTA ONCOLOGICA
- Risk of recurrence estimates with IHC4+C are tolerant of variations in staining and scoring: an analytical validity study
- (2015) Andrew Dodson et al. JOURNAL OF CLINICAL PATHOLOGY
- The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index
- (2015) Nobuyuki Arima et al. JOURNAL OF CLINICAL PATHOLOGY
- Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility
- (2015) Akira I Hida et al. JOURNAL OF CLINICAL PATHOLOGY
- Loss of antigenicity with tissue age in breast cancer
- (2015) Susan E Combs et al. LABORATORY INVESTIGATION
- An international study to increase concordance in Ki67 scoring
- (2015) Mei-Yin C Polley et al. MODERN PATHOLOGY
- An Interobserver Reproducibility Analysis of Ki67 Visual Assessment in Breast Cancer
- (2015) Ruohong Shui et al. PLoS One
- Proficiency testing in immunohistochemistry—experiences from Nordic Immunohistochemical Quality Control (NordiQC)
- (2015) Mogens Vyberg et al. VIRCHOWS ARCHIV
- Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy
- (2014) A. Sheri et al. ANNALS OF ONCOLOGY
- Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039)
- (2014) A. Leary et al. CLINICAL CANCER RESEARCH
- Standardized Ki67 Diagnostics Using Automated Scoring--Clinical Validation in the GeparTrio Breast Cancer Study
- (2014) F. Klauschen et al. CLINICAL CANCER RESEARCH
- A novel model for Ki67 assessment in breast cancer
- (2014) Quinci Romero et al. Diagnostic Pathology
- Assessment of the Ki67 labeling index: a Japanese validation ring study
- (2014) Naoki Niikura et al. Breast Cancer
- Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
- (2013) E. C. Inwald et al. BREAST CANCER RESEARCH AND TREATMENT
- Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study
- (2013) Yoshiki Mikami et al. CANCER SCIENCE
- Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
- (2013) G. von Minckwitz et al. CLINICAL CANCER RESEARCH
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial
- (2013) Daniel Hofmann et al. Trials
- Neoadjuvant treatments for triple-negative breast cancer (TNBC)
- (2012) G. von Minckwitz et al. ANNALS OF ONCOLOGY
- Targeting Adjuvant Chemotherapy: A Good Idea That Needs to Be Proven!
- (2012) Daniel F. Hayes JOURNAL OF CLINICAL ONCOLOGY
- Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting
- (2012) Lisa M. McShane et al. JOURNAL OF CLINICAL ONCOLOGY
- How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists
- (2012) Zsuzsanna Varga et al. PLoS One
- Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX
- (2011) S. Aebi et al. ANNALS OF ONCOLOGY
- Biospecimen Reporting for Improved Study Quality
- (2011) Helen M. Moore et al. BIOPRESERVATION AND BIOBANKING
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Steady Progress against HER2-Positive Breast Cancer
- (2011) Daniel F. Hayes NEW ENGLAND JOURNAL OF MEDICINE
- Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer
- (2010) Lesley-Ann Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Comparative validation of the SP6 antibody to Ki67 in breast cancer
- (2010) L. Zabaglo et al. JOURNAL OF CLINICAL PATHOLOGY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
- (2009) Steven M Teutsch et al. GENETICS IN MEDICINE
- Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer
- (2009) Frédérique Penault-Llorca et al. JOURNAL OF CLINICAL ONCOLOGY
- The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
- (2008) Robin L. Jones et al. BREAST CANCER RESEARCH AND TREATMENT
- Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics
- (2008) M. J. Ellis et al. JNCI-Journal of the National Cancer Institute
- Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials
- (2008) LANCET
- Direct multiplexed measurement of gene expression with color-coded probe pairs
- (2008) Gary K Geiss et al. NATURE BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started